Caricamento...
The successful use of dronabinol for failure to thrive secondary to intestinal dysmotility
INTRODUCTION: Symptoms of severe intestinal dysmotility decrease patients’ quality of life and may prevent them from sustaining adequate oral intake. Dronabinol is a synthetic cannabinoid that is labeled for use in AIDS-related anorexia and chemotherapy-associated nausea and vomiting that has additi...
Salvato in:
| Pubblicato in: | Int J Surg Case Rep |
|---|---|
| Autori principali: | , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Elsevier
2015
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4446691/ https://ncbi.nlm.nih.gov/pubmed/25974259 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijscr.2015.04.036 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|